Cargando...
ENGAGE and EMERGE: Truth and consequences?
The potential benefit of the anti‐amyloid drug aducanumab based on results of recent EMERGE and ENGAGE clinical trials has generated great controversy and has very important implications for the future of anti‐amyloid drug therapies. The two trials of 18‐month duration were done in patients with mil...
Gardado en:
| Publicado en: | Alzheimers Dement |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248059/ https://ncbi.nlm.nih.gov/pubmed/33656288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12286 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|